Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
397.6 USD | -2.36% | +3.95% | +29.70% |
Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
Financials (USD)
Sales 2024 * | 2.17B | Sales 2025 * | 2.52B | Capitalization | 12.29B |
---|---|---|---|---|---|
Net income 2024 * | 361M | Net income 2025 * | 416M | EV / Sales 2024 * | 5.33 x |
Net cash position 2024 * | 715M | Net cash position 2025 * | 1.04B | EV / Sales 2025 * | 4.47 x |
P/E ratio 2024 * |
35.5
x | P/E ratio 2025 * |
30.5
x | Employees | 5,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.84% |
Latest transcript on Medpace Holdings, Inc.
1 day | -2.36% | ||
1 week | +3.95% | ||
Current month | -1.63% | ||
1 month | -2.75% | ||
3 months | +34.06% | ||
6 months | +46.01% | ||
Current year | +29.70% |
Managers | Title | Age | Since |
---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 49 | 18-10-31 |
Jesse Geiger
PSD | President | 49 | 07-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Davenport
BRD | Director/Board Member | 72 | 18-08-12 |
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Director/Board Member | 64 | 18-08-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 2 M€ | -.--% | ||
0.49% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 397.6 | -2.36% | 423,451 |
24-04-23 | 407.2 | +8.21% | 808,514 |
24-04-22 | 376.3 | +1.15% | 357,745 |
24-04-19 | 372 | -0.62% | 221,668 |
24-04-18 | 374.3 | -2.12% | 219,892 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.70% | 12.29B | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+7.78% | 11.15B | |
-17.68% | 9.98B |
- Stock Market
- Equities
- MEDP Stock